Tesis Biosciences to Develop miRNA Biomarkers for mTBI Diagnosis
On the heels of its Genome Explorations acquisition, the company wants to create a biomarker panel to differentiate mild traumatic brain injury from PTSD.
Diagnostics Developer Early is Good Raises $4M in Seed Funding
The company will use the funds to complete clinical trials for its first product, BCDx, a laboratory-developed test for early bladder cancer detection.
MiRxes Launches Study for Pulmonary Hypertension Biomarkers in Asian Populations
The Singapore-based biotech company will evaluate its miRNA biomarker assay for early detection of pulmonary hypertension as part of the SPHERE study.
Cardior Pharmaceuticals MicroRNA PCR Kit Receives CE Marking
The kit measures circulating levels of miR-132 in patients receiving Cardior's experimental inhibitor of that microRNA to help treat heart failure patients.
Hummingbird Diagnostics Developing miRNA-Based Immunotherapy Predictor on Heels of Positive Study
The company published a pilot study showing that it's five-miRNA signature could predict which lung cancer patients survived longer on immunotherapy treatment.